One-year Outcomes of Deep Brain Stimulation in Refractory Tourette Syndrome in Korea.

This is the first study to report the DBS outcomes of 20 TS patients in a single center in Asia. Our study supports the efficacy of DBS targeting amGPi in refractory TS with no evident serious adverse events. Initial responses after DBS seem to be a predictor of long-term outcomes after surgery. This article is protected by copyright. All rights reserved.